Literature DB >> 19007043

Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

A Kotsiou1, E Diamanti, A Potamianou, H Parara, J Vovou, C Perisanidis, C Tes, C Tesseromatis.   

Abstract

The aim of this study was to determine whether the co-administration of acenocoumarin as anticoagulant and certain quinolones, i.e., cefapirin, pefloxacin and ciprofloxacin increased the levels of the given antibiotics and whether this resulted in a prolongation of prothrombin time. Seventy male albino Wistar rats aged 8-10 weeks and weighed 170 +/- 14 g were used and divided into seven groups (I, II, III, IV, V, VI, VII: n=10). The rats in group I received cefapirin via 1 g/kg/8h im injection. Group II received cefapirin via of 1 g/kg/8h im injection and 0.1 mg/kg/24h p.o. acenocoumarin. Group III received ciprofloxacin 0.18 mg/kg/24h im. Group IV received ciprofloxacin 0.18 mg/kg/24h im and 0.1 mg/kg/24h p.o. acenocoumarin. Group V received 10 mg/kg/24h pefloxacin im. Group VI received 10 mg/kg/24h pefloxacin im and 0.1 mg/kg/24h p.o. acenocoumarin while Group VII received only acenocoumarin 0.1 mg/kg/24h p.o. Drug administration was performed over a total of 5 doses in order to obtain steady state concentrations in the plasma and tissues. The animals were sacrificed by decapitation 2 h after the last antibiotic administration. Prothrombin time and antibiotic concentrations in the serum, femur and mandible were assessed. In the study, all the antibiotics were found to prolong prothrombine time following acenocoumarin administration. In addition, perfloxacin and ciproflaxin concentrations were increased in the serum and mandible after acenocoumarin treatment. Cepafirin levels remained unaffected after the administration of this anticoagulant. In conclusion, anticoagulant and quinolone co-administration led to significant pharmacokinetic interactions. Thus particular attention should be paid in the case of these drugs being used in combination in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007043     DOI: 10.1007/BF03191115

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  46 in total

1.  Levofloxacin and warfarin interaction.

Authors:  S L Ravnan; C Locke
Journal:  Pharmacotherapy       Date:  2001-07       Impact factor: 4.705

2.  Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.

Authors:  M Sioud; O Possot; C Elie; L Sibold; P Forterre
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

3.  Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats.

Authors:  E Tigka; I Daskala; G Rallis; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

4.  Portal-mesenteric pylephlebitis with hepatic abscesses in a patient with Crohn's disease treated successfully with anticoagulation and antibiotics.

Authors:  J Y Tung; J L Johnson; C A Liacouras
Journal:  J Pediatr Gastroenterol Nutr       Date:  1996-11       Impact factor: 2.839

5.  Light induced changes in quinolone levels in rat serum and tissues.

Authors:  C Tesseromatis; A Kotsiou; C Mourouzis; Th Saranteas; A Potamianou; E Vairactaris
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Oct-Dec       Impact factor: 2.441

6.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

7.  The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin.

Authors:  G L Nelsestuen; T H Zytkovicz; J B Howard
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

Review 8.  Overview of drug interactions with the quinolones.

Authors:  P G Davey
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

9.  Drug-related emergency department visits and hospital admissions.

Authors:  B S Prince; C M Goetz; T L Rihn; M Olsky
Journal:  Am J Hosp Pharm       Date:  1992-07

Review 10.  Drug-drug interactions with fluoroquinolones.

Authors:  C R Marchbanks
Journal:  Pharmacotherapy       Date:  1993 Mar-Apr       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.